COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Formulation of Monoclonal Antibody Therapies - 1st Edition - ISBN: 9780128233658

Formulation of Monoclonal Antibody Therapies

1st Edition

From Lab to Market

Editor: Amal Elkordy
Paperback ISBN: 9780128233658
Imprint: Academic Press
Published Date: 1st December 2021
Page Count: 245
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Formulation of Monoclonal Antibody Therapies: From Lab to Market covers a wide range of topics about therapeutic monoclonal antibodies (mAbs) with a focus on formulation aspects. Therapeutic monoclonal antibodies are used for treatment of chronic diseases. It brings together a comprehensive knowledge in one accessible volume. Starting with foundational information on monoclonal antibodies, the book then discusses the importance of biopharmaceutical products, monoclonal antibodies and biosimilars in treatment of chronic diseases, pharmaceutical aspects of mAbs, and how it can be administered. The industrial point of view and the clinical application of mAbs including in oncology, general medicine, rheumatology, hematology, dermatology, gastrointestinal tract, metabolic diseases and dentistry. Formulation of Monoclonal Antibody Therapies: From Lab to Market is essential reading for researchers in biotechnology and biopharmaceutical fields, academics and pharmaceutical industrial scientists, and university students in pharmaceutical and biopharmaceutical sciences.

Key Features

  • Covers details of recent advances in using mAbs
  • Examines how to overcome the challenges for formulations of therapeutic mAbs
  • Includes liposomal forms of mAbs


Researchers in biotechnology/biopharmaceutical fields, academics and pharmaceutical industrial scientists, and advanced university students in pharmaceutical and biopharmaceutical sciences

Table of Contents

  1. Introduction about antibodies
    2. Biosimilars
    3. Pharmaceutical aspects of mAbs
    4. Route of mAbs administration
    5. Industrial aspects of mAbs
    6. Application and marketed products of mAbs


No. of pages:
© Academic Press 2021
1st December 2021
Academic Press
Paperback ISBN:

About the Editor

Amal Elkordy

His research is on the areas of formulation of macromolecules, solid dosage forms, gene therapy, niosomal nano-particulate systems and enhancement of dissolution of poorly-water soluble drugs and has received several awards and presented work at several national and international conferences. Research outcomes are reachable to non-specialist audiences as well as to experts in the field of pharmaceutics and are recognised both nationally and internationally as evidenced from the significantly publish of over 130 publications, including journal articles and conference papers, most of which are published in high-impact journals and well-cited. Dr Elkordy has extensive teaching experience incorporating research findings as “Research informs Teaching”. He designed MSc Pharmaceutical and BioPharmaceutical Formulations which is one of the few courses in the UK covering biopharmaceuticals as well as pharmaceuticals.

Affiliations and Expertise

Professor of Pharmaceutics, Faculty of Health Sciences and Wellbeing, School of Pharmacy and Pharmaceutical Sciences, University of Sunderland, Sunderland, UK

Ratings and Reviews